AstraZeneca vaccine doses found at the Anagni plant will go to the European Union



[ad_1]

Vaccine doses AstraZeneca found at the Catalent factory in Agnani, 29 million in total, will be allocated toEuropean Union. This is what the President of the EU Commission said: Ursula Von der Leyen, who thus reassured Prime Minister Mario Draghi during the European Council working session on Covid-19. To Draghi, who reviewed the salient points of the matter and asked the president if she thinks it is correct that the doses of vaccines located in Belgium and the Netherlands continue to be for the European Union, totally or partially, Von der Leyen replied that all doses produced in the EU they will be addressed to the Member States. During the press conference at the end of the meeting, von der Leyen nevertheless clarified that “of the 29 million doses, 13 million are for Covax and 16 million are for the European Member States” and “it is important to us that vaccines are delivered. to Covax which is the main pillar to ensure that low-income countries have access to vaccines. “

In the course of his speech, Draghi allegedly stated that “European citizens have the feeling of having been misled by some pharmaceutical companies, I am thinking above all of AstraZeneca”, calling for “a fiscal policy framework that can get us out of the crisis “. The Prime Minister, therefore, does not beat around the bush when referring to the Anglo-Swedish pharmaceutical giant, of which he also recounted what happened in recent days at the Catalent plant in Agnani, in the province of Frosinone.

In the cold stores of Anagni, according to Nas reports, sent by Minister Speranza at the request of Draghi himself, pushed in turn at the personal suggestion of the president of the EU Commission, there are 29 million doses of AstraZeneca; instead of Johnson & Johnson, none because, pending authorizations, the raw material has not arrived. In fact, the Catalent plant had been running slowly until last month, because even AstraZeneca’s raw material was slow to arrive after problems found in the cell cultures of one of its plants in Belgium, in Puurs. And all this without stopping dose cut that AstraZeneca itself should ship to the EU: so far, the company has delivered just 18 million doses of the vaccine to Brussels, compared to 30 million expected. They report it toAGI European Union sources. “We hope that AstraZeneca has enough doses, either at Anagni or elsewhere, to deliver the 12 million doses left to reach 30 million doses by the end of the month,” explained the source.



[ad_2]